|
1
|
Pan HW, Li SC and Tsai KW: MicroRNA
dysregulation in gastric cancer. Curr Pharm Des. 19:1273–1284.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie
G, Ma Y and Shen L: Exosomal transfer of tumor-associated
macrophage-derived miR-21 confers cisplatin resistance in gastric
cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou X, Men X, Zhao R, Han J, Fan Z, Wang
Y, Lv Y, Zuo J, Zhao L, Sang M, et al: miR-200c inhibits
TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting
ZEB1 and ZEB2 in gastric cancer. Cancer Gene Ther. 25:68–76. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Z, Li Z, Li Y and Zang A: MicroRNA
and signaling pathways in gastric cancer. Cancer Gene Ther.
21:305–316. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li L, Zhu X, Shou T, Yang L, Cheng X, Wang
J, Deng L and Zheng Y: MicroRNA-28 promotes cell proliferation and
invasion in gastric cancer via the PTEN/PI3K/AKT signalling
pathway. Mol Med Rep. 17:4003–4010. 2017.PubMed/NCBI
|
|
6
|
Yang SM, Huang C, Li XF, Yu MZ, He Y and
Li J: miR-21 confers cisplatin resistance in gastric cancer cells
by regulating PTEN. Toxicology. 306:162–168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Petrocca F, Visone R, Onelli MR, Shah MH,
Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini
M, et al: E2F1-regulated MicroRNAs impair TGFbeta-dependent
cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell.
13:272–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Qu Y, Jingjing D, Deng T, Liu R,
Zhang L, Bai M, Li J, Zhou L, Ning T, et al: Integrated analysis of
the miRNA, gene and pathway regulatory network in gastric cancer.
Oncol Rep. 35:1135–1146. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang JX, Chen ZH, Chen DL, Tian XP, Wang
CY, Zhou ZW, Gao Y, Xu Y, Chen C, Zheng ZS, et al: LINC01410-
miR-532-NCF2-NF-κB feedback loop promotes gastric cancer
angiogenesis and metastasis. Oncogene. 37:2660–2675. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li T, Lu YY, Zhao XD, Guo HQ, Liu CH, Li
H, Zhou L, Han YN, Wu KC, Nie YZ, et al: MicroRNA-296-5p increases
proliferation in gastric cancer through repression of
Caudal-related homeobox 1. Oncogene. 33:783–793. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsuoka T and Yashiro M: The role of
PI3K/Akt/mTOR signaling in gastric carcinoma. Cancers (Basel).
6:1441–1463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Huang Z and Chen R: Microrna-136
promotes proliferation and invasion ingastric cancer cells through
Pten/Akt/P-Akt signaling pathway. Oncol Lett. 15:4683–4689.
2018.PubMed/NCBI
|
|
13
|
Dahia PL: PTEN, a unique tumor suppressor
gene. Endocr Relat Cancer. 7:115–129. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang YH, Lee HS and Kim WH: Promoter
methylation and silencing of PTEN in gastric carcinoma. Lab Invest.
82:285–291. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsukamoto Y, Nakada C, Noguchi T, Tanigawa
M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M and
Moriyama M: MicroRNA-375 is downregulated in gastric carcinomas and
regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer
Res. 70:2339–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng Y, Guo JJ, Liu YM and Wu XL:
MicroRNA-34A inhibits the growth, invasion and metastasis of
gastric cancer by targeting PDGFR and MET expression. Bioscience
Reports. 34:e001122014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang T, Hou J, Li Z, Zheng Z, Wei J, Song
D, Hu T, Wu Q, Yang JY and Cai JC: miR-15a-3p and miR-16-1-3p
negatively regulate twist1 to repress gastric cancer cell invasion
and metastasis. Int J Biol Sci. 13:122–134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang W, Tong JHM, Lung RWM, Dong Y, Zhao
J, Liang Q, Zhang L, Pan Y, Yang W, Pang JCS, et al: Targeting of
YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor
function in gastric adenocarcinoma. Mol Cancer. 14:522015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu L, Chen J, Ding C, Wei S, Zhu Y, Yang
W, Zhang X, Wei X and Han D: MicroRNA-137 contributes to dampened
tumorigenesis in human gastric cancer by Targeting AKT2. PLoS One.
10:e01301242015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu LY, Wang W, Zhao LY, Guo B, Yang J,
Zhao XG, Hou N, Ni L, Wang AY, Song TS, et al: miR-126 inhibits
growth of SGC-7901 cells by synergistically targeting the oncogenes
PI3KR2 and Crk, and the tumor suppressor PLK2. Int J Oncol.
45:1257–1265. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng R, Chen X, Yu Y, Su L, Yu B, Li J,
Cai Q, Yan M, Liu B and Zhu Z: miR-126 functions as a tumour
suppressor in human gastric cancer. Cancer Lett. 298:50–63. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen H, Li L, Wang S, Lei Y, Ge Q, Lv N,
Zhou X and Chen C: Reduced miR-126 expression facilitates
angiogenesis of gastric cancer through its regulation on VEGF-A.
Oncotarget. 5:11873–11885. 2014.PubMed/NCBI
|
|
25
|
Otsubo T, Akiyama Y, Hashimoto Y, Shimada
S, Goto K and Yuasa Y: MicroRNA-126 inhibits SOX2 expression and
contributes to gastric carcinogenesis. PLoS One. 6:e166172011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Z, Zhu J, Cao H, Ren H and Fang X:
miR-10b promotes cell invasion through RhoC-AKT signaling pathway
by targeting HOXD10 in gastric cancer. Int J Oncol. 40:1553–1560.
2012.PubMed/NCBI
|
|
27
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan MIN: MicroRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie M, Dart DA, Guo T, Xing XF, Cheng XJ,
Du H, Jiang WG, Wen XZ and Ji JF: MicroRNA-1 acts as a tumor
suppressor microRNA by inhibiting angiogenesis-related growth
factors in human gastric cancer. Gastric Cancer. 21:41–54. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kogo R, Mimori K, Tanaka F, Komune S and
Mori M: Clinical significance of miR-146a in gastric cancer cases.
Clin Cancer Res. 17:4277–4284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu F, Bu Z, Zhao F and Xiao D: Increased
T-helper 17 cell differentiation mediated by exosome-mediated
microRNA-451 redistribution in gastric cancer infiltrated T cells.
Cancer Sci. 109:65–73. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu C, Ren C, Han J, Ding Y, Du J, Dai N,
Dai J, Ma H, Hu Z, Shen H, et al: A five-microRNA panel in plasma
was identified as potential biomarker for early detection of
gastric cancer. Br J Cancer. 110:2291–2299. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen B, Yu S, Zhang Y, Yuan Y, Li X, Zhong
J and Feng J: miR-590-5p regulates gastric cancer cell growth and
chemosensitivity through RECK and the AKT/ERK pathway. OncoTargets
Ther. 9:6009–6019. 2016. View Article : Google Scholar
|
|
33
|
Zhou X, Ye F, Yin C, Zhuang Y, Yue G and
Zhang G: The interaction between miR-141 and lncRNA-H19 in
regulating cell proliferation and migration in gastric cancer. Cell
Physiol Biochem. 36:1440–1452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Han TS, Hur K, Xu G, Choi B, Okugawa Y,
Toiyama Y, Oshima H, Oshima M, Lee HJ, Kim VN, et al: MicroRNA-29c
mediates initiation of gastric carcinogenesis by directly targeting
ITGB1. Gut. 64:203–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao L and Vogt PK: Class I PI3K in
oncogenic cellular transformation. Oncogene. 27:5486–5496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Burgering BM and Coffer PJ: Protein kinase
B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.
Nature. 376:599–602. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Martini M, De Santis MC, Braccini L,
Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: An
updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Janku F, Yap TA and Meric-Bernstam F:
Targeting the PI3K pathway in cancer: Are we making headway? Nat
Rev Clin Oncol. 15:273–291. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang HW, Shin MG, Lee S, Kim JR, Park WS,
Cho KH, Meyer T and Heo WD: Cooperative activation of PI3K by Ras
and Rho family small GTPases. Mol Cell. 47:281–290. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Samuels Y and Ericson K: Oncogenic PI3K
and its role in cancer. Curr Opin Oncol. 18:77–82. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
Rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Soung YH, Lee JW, Nam SW, Lee JY, Yoo NJ
and Lee SH: Mutational analysis of AKT1, AKT2 and AKT3 genes in
common human carcinomas. Oncology. 70:285–289. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Maira SM, Galetic I, Brazil DP, Kaech S,
Ingley E, Thelen M and Hemmings BA: Carboxyl-terminal modulator
protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the
plasma membrane. Science. 294:374–380. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li VS, Wong CW, Chan TL, Chan AS, Zhao W,
Chu KM, So S, Chen X, Yuen ST and Leung SY: Mutations of PIK3CA in
gastric adenocarcinoma. BMC Cancer. 5:292005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ma J, Liu J, Wang Z, Gu X, Fan Y, Zhang W,
Xu L, Zhang J and Cai D: NF-kappaB-dependent MicroRNA-425
upregulation promotes gastric cancer cell growth by targeting PTEN
upon IL-1β induction. Mol Cancer. 13:402014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wen YG, Wang Q, Zhou CZ, Qiu GQ, Peng ZH
and Tang HM: Mutation analysis of tumor suppressor gene PTEN in
patients with gastric carcinomas and its impact on PI3K/AKT
pathway. Oncol Rep. 24:89–95. 2010.PubMed/NCBI
|
|
47
|
Samuels Y, Wang Z, Bardelli A, Silliman N,
Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, et al:
High frequency of mutations of the PIK3CA gene in human cancers.
Science. 304:5542004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shi J, Yao D, Liu W, Wang N, Lv H, Zhang
G, Ji M, Xu L, He N, Shi B and Hou P: Highly frequent PIK3CA
amplification is associated with poor prognosis in gastric cancer.
BMC Cancer. 12:502012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xiong J, Li Z, Zhang Y, Li D, Zhang G, Luo
X, Jie Z, Liu Y, Cao Y, Le Z, et al: PRL-3 promotes the peritoneal
metastasis of gastric cancer through the PI3K/Akt signaling pathway
by regulating PTEN. Oncol Rep. 36:1819–1828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pan H, Li T, Jiang Y, Pan C, Ding Y, Huang
Z, Yu H and Kong D: Overexpression of circular RNA ciRS-7 abrogates
the tumor suppressive effect of miR-7 on gastric cancer via
PTEN/PI3K/AKT signaling pathway. J Cell Biochem. 119:440–446. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhao S, Wang L, Zhang C, Deng Y, Zhao B,
Ren Y, Fu Y and Meng X: Inhibitor of growth 3 induces cell death by
regulating cell proliferation, apoptosis and cell cycle arrest by
blocking the PI3K/AKT pathway. Cancer Gene Ther. 25:240–247. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang SQ, Wang C, Chang LM, Zhou KR, Wang
JW, Ke Y, Yang DX, Shi HG, Wang R, Shi XL, et al: Geridonin and
paclitaxel act synergistically to inhibit the proliferation of
gastric cancer cells through ROS-mediated regulation of the
PTEN/PI3K/Akt pathway. Oncotarget. 7:72990–73002. 2016.PubMed/NCBI
|
|
53
|
Li C, Zhang J, Wu H, Li L, Yang C, Song S,
Peng P, Shao M, Zhang M, Zhao J, et al: Lectin-like oxidized
low-density lipoprotein receptor-1 facilitates metastasis of
gastric cancer through driving epithelial-mesenchymal transition
and PI3K/Akt/GSK3β activation. Sci Rep. 7:452752017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen D, Lin X, Zhang C, Liu Z, Chen Z, Li
Z, Wang J, Li B, Hu Y, Dong B, et al: Dual PI3K/mTOR inhibitor
BEZ235 as a promising therapeutic strategy against
paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR
pathway. Cell Death Dis. 9:1232018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Jin P and Sun L: Tu1968 the effect of a
novel Akt inhibitor MK-2206 on proliferation and chemosensitivity
of gastric cancer. Gastroenterology. 148 Suppl 1:S948–S949. 2015.
View Article : Google Scholar
|
|
56
|
Qi M, Jiao M, Li X, Hu J, Wang L, Zou Y,
Zhao M, Zhang R, Liu H, Mi J, et al: CUL4B promotes gastric cancer
invasion and metastasis-involvement of upregulation of HER2.
Oncogene. 37:1075–1085. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wu ZH, Lin C, Liu CC, Jiang WW, Huang MZ,
Liu X and Guo WJ: miR-616-3p promotes angiogenesis and EMT in
gastric cancer via the PTEN/AKT/mTOR pathway. Biochem Biophys Res
Commun. 501:1068–1073. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li NA, Wang W, Xu B and Gong H: miR-196b
regulates gastric cancer cell proliferation and invasion via
PI3K/AKT/mTOR signaling pathway. Oncol Lett. 11:1745–1749. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Liang M, Shi B, Liu J, He L, Yi G, Zhou L,
Yu G and Zhou X: Downregulation of miR203 induces overexpression of
PIK3CA and predicts poor prognosis of gastric cancer patients. Drug
Des Devel Ther. 9:3607–3616. 2015.PubMed/NCBI
|
|
60
|
Wei B, Song Y, Zhang Y and Hu M:
microRNA-449a functions as a tumor-suppressor in gastric
adenocarcinoma by targeting Bcl-2. Oncol Lett. 6:1713–1718. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Riquelme I, Tapia O, Leal P, Sandoval A,
Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM,
et al: miR-101-2, miR-125b-2 and miR-451a act as potential tumor
suppressors in gastric cancer through regulation of the
PI3K/AKT/mTOR pathway. Cell Oncol (Dordr). 39:23–33. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhang H, Cheng Y, Jia C, Yu S, Xiao Y and
Chen J: MicroRNA-29s could target AKT2 to inhibit gastric cancer
cells invasion ability. Med Oncol. 32:3422015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Xu M, Qin S, Cao F, Ding S and Li M:
MicroRNA-379 inhibits metastasis and epithelial-mesenchymal
transition via targeting FAK/AKT signaling in gastric cancer. Int J
Oncol. 51:867–876. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F,
Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng
K: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell
proliferation and radioresistance by targeting PTEN. BMC Cancer.
10:3672010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: miR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Li C, Song L, Zhang Z, Bai XX, Cui MF and
Ma LJ: MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal
transition in gastric cancer through up-regulating PTEN expression.
Oncotarget. 7:66989–67003. 2016.PubMed/NCBI
|
|
67
|
Zhang R, Guo Y, Ma Z, Ma G, Xue Q, Li F
and Liu L: Long non-coding RNA PTENP1 functions as a ceRNA to
modulate PTEN level by decoying miR-106b and miR-93 in gastric
cancer. Oncotarget. 8:26079–26089. 2017.PubMed/NCBI
|
|
68
|
Guo B, Liu L, Yao J, Ma R, Chang D, Li Z,
Song T and Huang C: miR-338-3p suppresses gastric cancer
progression through a PTEN-AKT axis by targeting P-REX2a. Mol
Cancer Res. 12:313–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang P, Guan Q, Zhou D, Yu Z, Song Y and
Qiu W: miR-21 inhibitors modulate biological functions of gastric
cancer cells via PTEN/PI3K/mTOR pathway. DNA Cell Biol. 37:38–45.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ni SJ, Zhao LQ, Wang XF, Wu ZH, Hua RX,
Wan CH, Zhang JY, Zhang XW, Huang MZ, Gan L, et al: CBX7 regulates
stem cell-like properties of gastric cancer cells via p16 and
AKT-NF-κB-miR-21 pathways. J Hematol Oncol. 11:172018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Wang X, Wang C, Zhang X, Hua R, Gan L,
Huang M, Zhao L, Ni S and Guo W: Bmi-1 regulates stem cell-like
properties of gastric cancer cells via modulating miRNAs. J Hematol
Oncol. 9:902016. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wang XF, Zhang XW, Hua RX, Du YQ, Huang
MZ, Liu Y, Cheng YF and Guo WJ: Mel-18 negatively regulates stem
cell-like properties through downregulation of miR-21 in gastric
cancer. Oncotarget. 7:63352–63361. 2016.PubMed/NCBI
|
|
74
|
Li H and Yang BB: Friend or foe: The role
of microRNA in chemotherapy resistance. Acta Pharmacol Sin.
34:870–879. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yan J, Dang Y, Liu S, Zhang Y and Zhang G:
lncRNA HOTAIR promotes cisplatin resistance in gastric cancer by
targeting miR-126 to activate the PI3K/AKT/MRP1 genes. Tumor Biol.
Tumour Biol. Nov 30–2016.(Epub ahead of print). View Article : Google Scholar :
|
|
76
|
Wang F, Li T, Zhang B, Li H, Wu Q, Yang L,
Nie Y, Wu K, Shi Y and Fan D: MicroRNA-19a/b regulates multidrug
resistance in human gastric cancer cells by targeting PTEN. Biochem
Biophys Res Commun. 434:688–694. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Cao W, Yang W, Fan R, Li H, Jiang J, Geng
M, Jin Y and Wu Y: miR-34a regulates cisplatin-induce gastric
cancer cell death by modulating PI3K/AKT/survivin pathway. Tumor
Biol. 35:1287–1295. 2014. View Article : Google Scholar
|
|
78
|
Eto K, Iwatsuki M, Watanabe M, Ida S,
Ishimoto T, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N
and Baba H: The microRNA-21/PTEN pathway regulates the sensitivity
of HER2-positive gastric cancer cells to trastuzumab. Ann Surg
Oncol. 21:343–350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Nishida N, Mimori K, Fabbri M, Yokobori T,
Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y and Mori M:
MicroRNA-125a-5p is an independent prognostic factor in gastric
cancer and inhibits the proliferation of human gastric cancer cells
in combination with trastuzumab. Clin Cancer Res. 17:2725–2733.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Chou J, Shahi P and Werb Z:
microRNA-mediated regulation of the tumor microenvironment. Cell
Cycle. 12:3262–3271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yang TS, Yang XH, Chen X, Wang XD, Hua J,
Zhou DL, Zhou B and Song ZS: MicroRNA-106b in cancer-associated
fibroblasts from gastric cancer promotes cell migration and
invasion by targeting PTEN. FEBS Lett. 588:2162–2169. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zucker S and Vacirca J: Role of matrix
metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis
Rev. 23:101–117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Liu G, Jiang C, Li D, Wang R and Wang W:
miRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in
gastric cancer. Tumor Biol. 35:9801–9806. 2014. View Article : Google Scholar
|
|
84
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Balakirev ES and Ayala FJ: Pseudogenes:
Are they ‘junk’ or functional DNA? Annu Rev Genet. 37:123–151.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Li L, Zhang J, Pan Q and Lei C:
MicroRNA-23a regulates cell migration and invasion by target PTEN
in gastric cancer. Int J Clin Exp Pathol. 9:877–887. 2016.
|
|
87
|
Yu B, Lv X, Su L, Li J, Yu Y, Gu Q, Yan M,
Zhu Z and Liu B: miR-148a functions as a tumor suppressor by
targeting CCK-BR via inactivating STAT3 and Akt in human gastric
cancer. PLoS One. 11:e01589612016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Tseng PC, Chen CL, Shan YS, Chang WT, Liu
HS, Hong TM, Hsieh CY, Lin SH and Lin CF: An increase in
integrin-linked kinase non-canonically confers NF-κB-mediated
growth advantages to gastric cancer cells by activating ERK1/2.
Cell Commun Signal. 12:692014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Zhang L, Lei J, Fang ZL and Xiong JP:
miR-128b is down-regulated in gastric cancer and negatively
regulates tumour cell viability by targeting PDK1/Akt/NF-κB axis. J
Biosci. 41:77–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Sha M, Ye J, Zhang LX, Luan ZY, Chen YB
and Huang JX: Celastrol induces apoptosis of gastric cancer cells
by miR-21 inhibiting PI3K/Akt-NF-κB signaling pathway.
Pharmacology. 93:39–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Paget S: The distribution of secondary
growths in cancer of the breast. Lancet. 133:571–573. 1889.
View Article : Google Scholar
|
|
92
|
Lauschke VM, Mkrtchian S and
Ingelman-Sundberg M: The role of microRNAs in liver injury at the
crossroad between hepatic cell death and regeneration. Biochem
Biophys Res Commun. 482:399–407. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Nagaraja AK, Creighton CJ, Yu Z, Zhu H,
Gunaratne PH, Reid JG, Olokpa E, Itamochi H, Ueno NT, Hawkins SM,
et al: A link between mir-100 and FRAP1/mTOR in clear cell ovarian
cancer. Mol Endocrinol. 24:447–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Kwiatkowski DJ: Rhebbing up mTOR: New
insights on TSC1 and TSC2, and the pathogenesis of tuberous
sclerosis. Cancer Biol Ther. 2:471–476. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Kim LC, Cook RS and Chen J: mTORC1 and
mTORC2 in cancer and the tumor microenvironment. Oncogene.
36:2191–2201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Huang T, Kang W, Zhang B, Wu F, Dong Y,
Tong JH, Yang W, Zhou Y, Zhang L, Cheng AS, et al: miR-508-3p
concordantly silences NFKB1 and RELA to inactivate canonical NF-κB
signaling in gastric carcinogenesis. Mol Cancer. 15:92016.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhou X, Xia Y, Su J and Zhang G:
Down-regulation of miR-141 induced by Helicobacter pylori
promotes the invasion of gastric cancer by targeting STAT4. Cell
Physiol Biochem. 33:1003–1012. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
He B, Xiao YF, Tang B, Wu YY, Hu CJ, Xie
R, Yang X, Yu ST, Dong H, Zhao XY, et al: hTERT mediates gastric
cancer metastasis partially through the indirect targeting of ITGB1
by microRNA-29a. Sci Rep. 6:219552016. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Huang N, Wu Z, Lin L, Zhou M, Wang L, Ma
H, Xia J, Bin J, Liao Y and Liao W: miR-338-3p inhibits
epithelial-mesenchymal transition in gastric cancer cells by
targeting ZEB2 and MACC1/Met/Akt signaling. Oncotarget.
6:15222–15234. 2015.PubMed/NCBI
|
|
100
|
Liu J, Wang X, Yang X, Liu Y, Shi Y, Ren J
and Guleng B: miRNA423-5p regulates cell proliferation and invasion
by targeting trefoil factor 1 in gastric cancer cells. Cancer Lett.
347:98–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Zhang J, Liu H, Hou L, Wang G, Zhang R,
Huang Y, Chen X and Zhu J: Circular RNA_LARP4 inhibits cell
proliferation and invasion of gastric cancer by sponging miR-424-5p
and regulating LATS1 expression. Mol Cancer. 16:1512017. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Han X, Chen Y, Yao N, Liu H and Wang Z:
MicroRNA let-7b suppresses human gastric cancer malignancy by
targeting ING1. Cancer Gene Ther. 22:122–129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Wang JY, Huang TJ, Chen FM, Hsieh MC, Lin
SR, Hou MF and Hsieh JS: Mutation analysis of the putative tumor
suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Virchows
Arch. 442:437–443. 2003.PubMed/NCBI
|
|
104
|
Velho S, Oliveira C, Ferreira A, Ferreira
AC, Suriano G, Schwartz S Jr, Duval A, Carneiro F, Machado JC,
Hamelin R and Seruca R: The prevalence of PIK3CA mutations in
gastric and colon cancer. Eur J Cancer. 41:1649–1654. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Staal SP: Molecular cloning of the akt
oncogene and its human homologues AKT1 and AKT2: Amplification of
AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci
USA. 84:5034–5037. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Cheng Y, Li Y, Liu D, Zhang R and Zhang J:
miR-137 effects on gastric carcinogenesis are mediated by targeting
Cox-2-activated PI3K/AKT signaling pathway. FEBS Lett.
588:3274–3281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Lu W, Xu Z, Zhang M and Zuo Y: miR-19a
promotes epithelial-mesenchymal transition through PI3K/AKT pathway
in gastric cancer. Int J Clin Exp Pathol. 7:7286–7296.
2014.PubMed/NCBI
|
|
108
|
Li F, Liu B, Gao Y, Liu Y, Xu Y, Tong W
and Zhang A: Upregulation of MicroRNA-107 induces proliferation in
human gastric cancer cells by targeting the transcription factor
FOXO1. FEBS Lett. 588:538–544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang
X, Jiang L, Sun Z, Miao Z and Xu H: MicroRNA-335 acts as a
metastasis suppressor in gastric cancer by targeting Bcl-w and
specificity protein 1. Oncogene. 31:1398–1407. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Zhao Y, Dong Q and Wang E: MicroRNA-320
inhibits invasion and induces apoptosis by targeting CRKL and
inhibiting ERK and AKT signaling in gastric cancer cells. Onco
Targets Ther. 10:1049–1058. 2017. View Article : Google Scholar : PubMed/NCBI
|
